Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients

• Sponsor: Hisar Intercontinental Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT06016595
• Collaborator: (none)
• Enrollment: 112
• Location: 1
• Actual Duration (Months): 40.2
• Patients Per Site Per Month: 2.8

Study Details

Study Description

Brief Summary

Chronic prostatitis/chronic pelvic pain syndrome (CPPS) is a common health problem among men and can cause severe quality of life. The pathophysiology of CPPS is still poorly understood and effective treatments are a challenging issue. This study aims to investigate the possible relationship between the presence of microorganisms in the prostatic fluid and symptom severity by presenting a retrospective analysis based on data from CPPS patients.

Condition or Disease	Intervention/Treatment	Phase
Chronic Prostatitis With Chronic Pelvic Pain Syndrome	Diagnostic Test: Chronic prostatitis/chronic pelvic pain syndrome

Detailed Description

This study is based on data from 112 CPPS patients aged 20-60 years. Various variables such as demographic information of the patients, International Prostate Symptom Score (I-PSS), which evaluates CPPS symptoms, inflammatory and non-inflammatory symptoms of CPPS, baseline scores of the International Index of Erectile Function (IIEF), which evaluates erectile function, and the presence of microorganisms in the prostate fluid were analyzed retrospectively.

Study Design

• Study Type: Observational
• Actual Enrollment: 112 participants
• Observational Model: Case-Only
• Time Perspective: Retrospective
• Official Title: Retrospective Data Analysis in Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients: Evaluation of the Relationship Between Presence of Microorganism and Severity of Symptom
• Actual Study Start Date: Jan 1, 2020
• Actual Primary Completion Date: Dec 31, 2022
• Actual Study Completion Date: May 10, 2023

Arms and Interventions

Arm	Intervention/Treatment
singel	Diagnostic Test: Chronic prostatitis/chronic pelvic pain syndrome; Chronic prostatitis/chronic pelvic pain syndrome UPOINT

Outcome Measures

Primary Outcome Measures

1. Correlation between androflor pcr positive patients and uopint and nih-cpsi [2 years]

   Those with positive and negative Androflor PCR test will be evaluated. testicular torsion

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years to 60 Years
• Sexes Eligible for Study: Male
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Patients who were diagnosed with chronic prostatitis/chronic pelvic pain syndrome and whose prostate fluid was taken with prostate massage and androflor testis were studied were included.

Exclusion Criteria:

• acute and/or chronic bacterial prostatitis, active history of genitourinary cancer, history of recent prostate surgery the diagnosis of neurological diseases affecting the bladder was determined

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hisar Intercontinental Hospital	Istanbul		Turkey	34768

Sponsors and Collaborators

• Hisar Intercontinental Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Basri Cakiroglu, Ass. Prof., Hisar Intercontinental Hospital
• ClinicalTrials.gov Identifier: NCT06016595
• Other Study ID Numbers: 16.08.2023/23-43
• First Posted: Aug 29, 2023
• Last Update Posted: Aug 29, 2023
• Last Verified: Aug 1, 2023

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Prostatitis; Syndrome; Pelvic Pain; Chronic Disease; Somatoform Disorders

Study Results

No Results Posted as of Aug 29, 2023